IRadimed Corporation (IRMD) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for IRadimed Corporation, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 55.05x | 36.23x | 34.80x | 27.70x | 61.18x | 201.91x |
| P/B Ratio | 13.08x | 8.03x | 8.38x | 4.82x | 7.90x | 4.50x |
| P/S Ratio | 14.77x | 9.51x | 9.13x | 6.67x | 13.64x | 8.72x |
| Profitability | ||||||
| Gross Margin | 76.7% | 76.9% | 76.5% | 77.4% | 76.6% | 74.3% |
| Operating Margin | 31.2% | 30.0% | 30.6% | 29.3% | 23.5% | -2.4% |
| Net Margin | 26.8% | 26.3% | 26.2% | 24.1% | 22.3% | 4.3% |
| EBITDA Margin | 34.0% | 31.1% | 31.7% | 30.6% | 26.8% | 1.8% |
| Liquidity | ||||||
| Current Ratio | 7.98x | 8.84x | 4.65x | 9.06x | 11.18x | 12.96x |
| Quick Ratio | 6.84x | 7.62x | 3.87x | 8.43x | 10.54x | 12.16x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.03x | 0.03x | 0.03x | 0.04x |
YoY = year-over-year change. Source: FMP..